<VariationArchive VariationID="2960648" VariationName="NM_153006.3(NAGS):c.535dup (p.Ala179fs)" VariationType="Duplication" Accession="VCV002960648" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3123150" VariationID="2960648">
      <GeneList>
        <Gene Symbol="NAGS" FullName="N-acetylglutamate synthase" GeneID="162417" HGNC_ID="HGNC:17996" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44004622" stop="44009068" display_start="44004622" display_stop="44009068" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42082031" stop="42086435" display_start="42082031" display_stop="42086435" Strand="+" />
          </Location>
          <OMIM>608300</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_153006.3(NAGS):c.535dup (p.Ala179fs)</Name>
      <CanonicalSPDI>NC_000017.11:44005743:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44005743" stop="44005744" display_start="44005743" display_stop="44005744" variantLength="1" positionVCF="44005743" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42083111" stop="42083112" display_start="42083111" display_stop="42083112" variantLength="1" positionVCF="42083111" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>A179fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42083113dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42083113dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44005745dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44005745dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008106.1" sequenceAccession="NG_008106" sequenceVersion="1" change="g.6082dup">
            <Expression>NG_008106.1:g.6082dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023338.1" sequenceAccession="NG_023338" sequenceVersion="1" change="g.3726dup">
            <Expression>NG_023338.1:g.3726dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023338.2" sequenceAccession="NG_023338" sequenceVersion="2" change="g.3701dup">
            <Expression>NG_023338.2:g.3701dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_136660.1" sequenceAccession="NG_136660" sequenceVersion="1" change="g.301dup">
            <Expression>NG_136660.1:g.301dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153006.3" sequenceAccession="NM_153006" sequenceVersion="3" change="c.535dup" MANESelect="true">
            <Expression>NM_153006.3:c.535dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_694551.1" sequenceAccession="NP_694551" sequenceVersion="1" change="p.Ala179fs">
            <Expression>NP_694551.1:p.Ala179fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153006.3(NAGS):c.535dup (p.Ala179fs) AND Hyperammonemia, type III" Accession="RCV003817383" Version="1">
        <ClassifiedConditionList TraitSetID="612">
          <ClassifiedCondition DB="MedGen" ID="C0268543">Hyperammonemia, type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12594532</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="612" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3432" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hyperammonemia due to N-acetylglutamate synthase deficiency</ElementValue>
                <XRef ID="MONDO:0009377" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NAG synthetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperammonemia, type III</ElementValue>
                <XRef ID="Hyperammonemia%2C+type+III/8576" DB="Genetic Alliance" />
                <XRef ID="57119000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NAGSD</ElementValue>
                <XRef Type="MIM" ID="237310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7158" />
                <XRef ID="7158" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Decreased-Citrulline.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased Citrulline, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Decreased-Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Decreased Citrulline, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Nags-Deficiency-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, N-Acetylglutamate Synthase (NAGS) Deficiency, 2012</CitationText>
              </Citation>
              <XRef ID="927" DB="Orphanet" />
              <XRef ID="C0268543" DB="MedGen" />
              <XRef ID="MONDO:0009377" DB="MONDO" />
              <XRef Type="MIM" ID="237310" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8573395" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="12137918|MedGen:C0268543" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004618952" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12594532</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NAGS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala179Glyfs*117) in the NAGS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAGS are known to be pathogenic (PMID: 12594532).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAGS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42083111_42083112insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268543" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8573395" TraitType="Disease" MappingType="XRef" MappingValue="C0268543" MappingRef="MedGen">
        <MedGen CUI="C0268543" Name="Hyperammonemia, type III" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

